Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: J Hypertens. 2020 May;38(5):954–960. doi: 10.1097/HJH.0000000000002359

Table 3.

Association of baseline atenolol with gout, HR (95% CI)

Unadjusted Age/sex/race Adjusted
Without atenolol Events/Total With atenolol Events/Total HR (95% CI) P HR (95% CI) P
Chlorthalidone 306/10563 12/437 1.01 (0.57–1.80) 0.98 1.18 (0.66–2.11) 0.58
Amlodipine 116/6293 4/229 1.03 (0.38–2.78) 0.96 1.10 (0.41–3.00) 0.85
Lisinopril 152/6028 7/262 1.12 (0.53–2.39) 0.77 1.21 (0.56–2.59) 0.63
Overall 574/23036 23/928 1.05 (0.69–1.60) 0.80 1.18 (0.78–1.80) 0.43

Abbreviations: HR, hazard ratio; CI, confidence interval

Note: These analyses are presented unadjusted and adjusted for age, sex, and race/ethnicity as atenolol was not a randomized medication.